ClinicalTrials.govpublic full text
Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
kidney medullary carcinoma, loss of ini 1 protein expression, stage iii renal cell cancer ajcc v8, stage iv renal cell cancer ajcc v8
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 123459 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.